Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for RS given its working-capital-intensive metals distribution model, LIFO inventory accounting that creates divergence between reported and FIFO margins, and capital allocation priorities that tie shareholder returns to operating cash flow generation.

Composite Trajectory: Mixed

Annual results show a clear three-year deterioration: net income fell from $1,340.1M (2023) to $878.0M (2024) to $741.6M (2025); diluted EPS declined from $22.64 to $15.56 to $13.98; operating margin compressed from 11.7% to 8.4% to 7.1%; and operating cash flow dropped from $1,671.3M to $1,429.8M to $831.4M (10-K 2025, Consolidated Statements of Operations and Cash Flows). Conversely, the most recent quarterly period shows strong year-over-year improvement: Q2 2026 net sales rose 26.5% to $4,630.0M from $3,659.8M; operating margin expanded to 9.5% from 8.5%; diluted EPS increased 42.3% to $6.29 from $4.42; and YTD operating cash flow grew to $313.6M from $293.5M (10-Q Q2 2026, Consolidated Statements of Operations and Cash Flows). The balance sheet has deteriorated steadily with rising leverage and working capital absorption.

2. Red Flags

• Annual operating margin declined three consecutive years: 11.7% (2023) → 8.4% (2024) → 7.1% (2025) (10-K 2025, Consolidated Statements of Operations)
• Annual operating cash flow fell 50% over two years: $1,671.3M (2023) → $1,429.8M (2024) → $831.4M (2025) (10-K 2025, Consolidated Statements of Cash Flows)
• Net debt-to-total capital increased steadily: 10.2% (Dec 2024) → 14.4% (Dec 2025) → 16.2% (Jun 2026) (10-K 2025, MD&A; 10-Q Q2 2026, MD&A)
• LIFO gross margin declined despite revenue growth: annual 30.7%→29.7%→28.7%; Q2 2026 28.1% vs 29.7% in Q2 2025 (10-K 2025, MD&A; 10-Q Q2 2026, MD&A)
• Working capital pressure intensified: accounts receivable grew 43.5% ($1,539.9M→$2,210.4M) and inventories grew 6.3% ($2,187.8M→$2,325.4M) from Dec 2025 to Jun 2026 (10-Q Q2 2026, Consolidated Balance Sheets)
• Total debt rose from $1,151.1M (Dec 2024) to $1,427.7M (Dec 2025) to $1,663.9M (Jun 2026) (10-K 2025, Note 10; 10-Q Q2 2026, Consolidated Balance Sheets)
• Share repurchases funded partly by debt: $594.1M repurchased in 2025 while net borrowings increased $277M; $234.2M repurchased YTD 2026 with reduced net borrowings (10-K 2025, Consolidated Statements of Cash Flows; 10-Q Q2 2026, Consolidated Statements of Cash Flows)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results deteriorated over the three-year period: net income attributable to Reliance fell from $1,335.9M (2023) to $875.2M (2024) to $739.4M (2025); diluted EPS declined from $22.64 to $15.56 to $13.98; operating income dropped from $1,739.5M to $1,160.0M to $1,012.7M; and operating margin compressed from 11.7% to 8.4% to 7.1% (10-K 2025, Consolidated Statements of Operations). Gross profit was flat at $4,107.5M in 2025 vs $4,106.6M in 2024 but down from $4,547.3M in 2023, with LIFO gross margin declining 100 bps year-over-year in 2025 to 28.7%. Quarterly trends reversed sharply: Q2 2026 net sales jumped 26.5% to $4,630.0M from $3,659.8M; operating income rose 41.4% to $441.6M from $312.2M; operating margin expanded to 9.5% from 8.5%; net income increased 38.1% to $323.6M from $234.2M; and diluted EPS grew 42.3% to $6.29 from $4.42 (10-Q Q2 2026, Consolidated Statements of Operations). YTD 2026 operating margin of 9.4% exceeded 8.2% in YTD 2025.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow declined precipitously: $1,671.3M (2023) → $1,429.8M (2024) → $831.4M (2025), a 50% two-year drop driven by higher working capital requirements from rising tons sold and metals pricing (10-K 2025, Consolidated Statements of Cash Flows). The 2025 decline of $598.4M versus 2024 reflected a $136.4M net income decline and increased working capital investment, primarily accounts receivable (-$195.4M) and inventories (-$154.8M). YTD 2026 showed modest improvement: operating cash flow rose to $313.6M from $293.5M in YTD 2025 (+$20.1M), despite larger working capital builds (AR -$673.3M, Inventory -$139.1M) offset by higher payables (+$276.2M) and increased profitability (10-Q Q2 2026, Consolidated Statements of Cash Flows). Capital expenditures decreased annually ($468.8M→$430.6M→$328.9M) and YTD ($174.5M→$157.6M). Free cash flow (operating minus capex) was $502.5M in 2025 vs $999.2M in 2024; YTD 2026 free cash flow was $156.0M vs $119.0M in YTD 2025.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Leverage and working capital absorption have worsened consistently. Net debt-to-total capital rose from 10.2% (Dec 2024) to 14.4% (Dec 2025) to 16.2% (Jun 2026) (10-K 2025, MD&A; 10-Q Q2 2026, MD&A). Total debt increased from $1,151.1M (Dec 2024) to $1,427.7M (Dec 2025) to $1,663.9M (Jun 2026) (10-K 2025, Note 10; 10-Q Q2 2026, Consolidated Balance Sheets). Cash declined from $318.1M (Dec 2024) to $216.6M (Dec 2025) before partially recovering to $235.4M (Jun 2026). Working capital assets (accounts receivable + inventories) grew from $3,368.8M (Dec 2024) to $3,727.7M (Dec 2025) to $4,535.8M (Jun 2026), outpacing total equity growth ($7,230.6M→$7,179.5M→$7,411.2M). Current ratio fell from 3.21x (Dec 2024) to 4.88x (Dec 2025) to 4.30x (Jun 2026) due to current liability composition changes (short-term debt repaid, payables increased). The LIFO reserve grew from $434.9M (Dec 2024) to $548.6M (Dec 2025) to $698.6M (Jun 2026), reflecting cumulative inventory cost inflation (10-K 2025, Note 4; 10-Q Q2 2026, MD&A).

6. Data Gaps

• Standalone quarterly results for Q1 2026, Q3 2025, Q4 2025 (only Q2 and YTD periods provided in 10-Q)
• Quarterly cash flow statements for discrete quarters (only YTD provided in 10-Q)
• 2023 net debt-to-total capital ratio (not disclosed in 10-K)
• Full-year 2026 guidance or outlook (not in filings)
• FIFO gross profit figures for full years 2023-2025 (only disclosed for 2024-2025 in MD&A overview)
• Same-store metrics for quarters prior to Q2 2026